Clinical trial Recruiting at 3 sites Observational Ages 18 and up Women only

How medicines you take show up in breast milk and how much your baby might get

Official title: Medication Concentrations in Human Milk (MedMilk) and Potential Adverse Effects in Breastfed Infants: an Exploratory Clinical Study

Run by University Hospital Bispebjerg and Frederiksberg · NCT07346716 · Data updated 2026-11-12

See how medicines taken by breastfeeding women show up in breast milk and how much their babies might be exposed to.

More Breastfeeding trials

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment250 (estimated)
SponsorUniversity Hospital Bispebjerg and Frederiksberg
Academic / other
Locations3 sites (Copenhagen and 2 other locations)
StatusRecruiting
StartedDecember 20, 2024
Main results expectedJanuary 2028
Study endsJanuary 2030
Registry record updatedJanuary 16, 2026
Trial IDNCT07346716 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Breastfeeding women aged 18 or older who are currently taking one or more prescription or over-the-counter medicines and can provide informed consent and milk/urine samples are ideal candidates.

Probably not a fit

Pregnant women, people who are not breastfeeding, or those with known significant drug-drug interactions at the time of sampling are excluded and would not benefit from participating.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational study enrolls breastfeeding women who are already taking prescription or over-the-counter medicines as part of routine care. Participants provide timed small breast milk samples, one urine sample, and answer questions about maternal and infant health and breastfeeding patterns. Samples are stored and later analyzed using UPLC-MS/MS to measure drug concentrations and calculate relative infant doses where data are sufficient. No experimental drugs are given and results will be reported descriptively to add to knowledge about medication transfer into human milk.

Why it matters

Potential benefit: If successful, the results could lead to safer prescribing and clearer counseling for breastfeeding mothers by providing data on how much medicine reaches an infant through milk.

How similar studies have gone: Previous small pharmacokinetic and case studies have measured drug levels in breast milk, but systematic prospective multi-drug data remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Lactating women aged ≥18 years
* Current use of one or more prescription or over-the-counter (classified within the ATC system) drugs
* Able and willing to provide written informed consent

Exclusion Criteria:

* Current pregnancy during sample collection
* Known and clinically significant pharmacokinetic drug-drug interactions at the time of sampling

Where it's running

  • Department of Clinical Pharmacology
    Copenhagen, Denmark
    Recruiting
  • Mental health services, Capital Region of Denmark
    Copenhagen, Denmark
    Recruiting
  • Department of Obstetrics and Gynecology, Herlev Hospital
    Herlev, Denmark
    Recruiting

Study contacts

  • Principal investigator: Jon Traerup Andersen, Professor, MD, PhD — Department of Clinical Pharmacology, Bispbjeg and Frederiksberg Hospital
  • Study coordinator: Ditte Resendal Gotfredsen, MD
  • Email: ditte.resendal.gotfredsen@regionh.dk
  • Phone: +4521472051

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.